| |
|
|
Total |
CMV reactivation |
no reactivation |
p-value |
| |
|
n |
% |
n |
% |
n |
% |
|
| Total included |
|
22 |
|
14 |
|
8 |
|
|
| Sex |
male |
11 |
50 |
8 |
57 |
3 |
38 |
0,659 |
| |
female |
11 |
50 |
6 |
43 |
5 |
63 |
|
| Age (years) |
median (range) |
56 |
(18-66) |
58 |
(19-66) |
52 |
(18-61) |
0,165 |
| Diagnosis |
AML |
8 |
36 |
5 |
36 |
3 |
38 |
0,423 |
| |
MM |
5 |
23 |
2 |
14 |
3 |
38 |
|
| |
NHL |
6 |
27 |
5 |
36 |
1 |
13 |
|
| |
Hodgkin |
1 |
5 |
1 |
7 |
0 |
0 |
|
| |
ALL |
1 |
5 |
1 |
7 |
0 |
0 |
|
| |
MDS |
1 |
5 |
0 |
0 |
1 |
13 |
|
| HLA mismatch |
|
2 |
9 |
2 |
14 |
0 |
0 |
0,515 |
| Donor |
related |
17 |
77 |
11 |
79 |
6 |
75 |
1,000 |
| |
unrelated |
5 |
23 |
3 |
21 |
2 |
25 |
|
| Conditioning |
nma |
19 |
86 |
13 |
93 |
6 |
75 |
0,527 |
| |
ma |
3 |
14 |
1 |
7 |
2 |
25 |
|
| ATG |
|
7 |
32 |
4 |
29 |
3 |
38 |
1,000 |
| CMV serostatus |
R+/D+ |
8 |
36 |
8 |
57 |
0 |
0 |
0,010 |
| |
R+/D- |
9 |
41 |
5 |
36 |
4 |
50 |
|
| |
R-/D+ |
5 |
23 |
1 |
7 |
4 |
50 |
|
|
R-/D- |
0 |
0 |
0 |
0 |
0 |
0 |
|
AML: Acute Myeloid Leukemia; MM: Multiple Myeloma; NHL: Non-Hodgkin Lymphoma; ALL: Acute Lymphatic Leukemia; MDS: Myelodysplastic Syndrome; NMA: Nonmyeloablative;
MA: Myeloablative; ATG: Anti-thymocyte Globulin; CMV: Cytomegalovirus; SCT: Stem Cell Transplantation
Differences between groups were compared using the Fisher’s Exact test in case of discrete variables.
In case of continues variables the Mann-Whitney test was used. |
